140 results
Page 4 of 7
8-K
EX-1.1
uypulkk
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
z8nlsk4vkovj0
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.2
udj red29
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
viqr0eqg7hq wko4da3
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
F-6EF
alyk954vywi lv33eo
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
F-6EF
EX-99
9zl6f
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
S-8
2z50f9
30 Aug 19
Registration of securities for employees
12:30pm
S-8
EX-5.1
1eixp3r5lsrsrwy
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
nbnxutx8p mrgemh
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
w4vhovgbrm4udyr4da
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
0v4x15ecyo
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
x4in4
27 Jun 19
Departure of Directors or Certain Officers
8:08am